The NIH cuts affected over 115 clinical trials studying cancer and nearly 100 studying infectious disease, researchers found.
Conducting studies in over 50 countries and regions, Caidya specializes in oncology and hematology, rare diseases, pediatrics, cell and gene therapy, cardiovascular, and dermatology. It has emerged as ...
Gueddar, Senior Director, Commercial Strategy, IQVIA Clinical Trial Financial Suite | Streamline and manage every aspect of ...
A new study has shown that a clinical tool developed by the University of Liverpool and The Walton Center can accurately ...
Trial management has become one of the most decisive factors in determining whether diagnostic and medtech innovations make it to market successfully. For companies developing in vitro diagnostics and ...
This session will explore best practices for sourcing and managing comparator products in clinical trials. It is designed to ...
Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...
FibroBiologics, Inc. (Nasdaq: FBLG) ('FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Multicenter, randomized, controlled study will evaluate Company’s next-generation multichannel TMS technology in reducing ...
The findings, published in JAMA Internal Medicine, build on earlier research documenting the NIH’s unprecedented wave of ...
By implementing appropriate security measures, threat assessment protocols, and compliance-driven policies, healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback